Health Trials

Post-Allogeneic Stem Cell Transplant Complications

1

Review clinical trials related to Post-Allogeneic Stem Cell Transplant Complications. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Available

TETRAVI Expanded Access Program

This Expanded Access Program (EAP) allows qualified physicians within Texas to obtain access to multivirus-specific cytotoxic T lymphocytes (VSTs) developed under Baylor College of Medicine's TETRAVI program (NCT04013802) for the treatment of persistent or recurrent infections with EBV, CMV, adenovirus, or BK virus in pediatric patients being treated in Texas who have received allogeneic stem cell transplants and have no other suitable therapeutic options.

Trial details
Age: Up to 17Biological sex: AllType: Expanded AccessSponsor: Baylor College of MedicineUpdated: Aug 5, 2025
Eligibility criteria

Patients <18 years of age. [+4]

Patients with active uncontrolled infections unrelated to the viruses mentioned. [+2]

Read more